ML18156A415

From kanterella
Revision as of 23:50, 20 October 2019 by StriderTol (talk | contribs) (Created page by program invented by StriderTol)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Export License Issued to Cambridge Isotope Laboratories Inc., XMAT433-01
ML18156A415
Person / Time
Site: 11006181
Issue date: 06/04/2018
From: Peter Habighorst
NRC/OIP
To: Ionta G
Cambridge Isotope Labs
Savoy J
References
Download: ML18156A415 (3)


Text

EXPORT LICENSE NRC FORM 250 (10-07)

NRC LICENSE NO.: XMAT433/01 Page 1 of 3 UNITED STATES OF AMERICA Nuclear Regulatory Commission DOCKET NO.: 11006181 Washington, D.C. 20555 LICENSE EXPIRES: January 01, 2022 Pursuant to the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974 and the regulations of the Nuclear Regulatory Commission (NRC)issued pursuant thereto, and in reliance on statements and representations heretofore made by the licensee, a license Is hereby issued to the licensee authorizing the export of the materials and/or production or utilization facilities listed below, subject to the terms and conditions herein.

LICENSEE ULTIMATE CONSIGNEE(S)IN FOREIGN COUNTRY(IES)

Cambridge Isotope Laboratories Inc. See page 2 50 Frontage Road Andover, MA 01810 Attn: Gary lonta INTERMEDIATE CONSIGNEE(S)IN FOREIGN COUNTRY(IES) OTHER U.S. PARTY(IES) TO EXPORT See pages 2 and 3 NONE APPLICANT'S REFERENCE NO.: Application Dated 09/25/17 ULTIMATE DESTINATION(S): Republic of Korea QUANTITY(IES) DESCRIPTION OF MATERIAL(S)OR FACILITY(IES)

This license is amended to: 1)include two additional intermediate consignees, and two additional ultimate consignees: and 2) extend the date of expiration from January 1, 2020 to January 1. 2022.

The licensee is authorized to export 10.000 kilograms of deuterium gas, deuterium oxide, and deuterium compounds to be sold and/or distributed into the Republic of Korea's medical, pharmaceutical, chemical, and industrial markets, where the material will be used in small quantities for scientific research.

THIS LICENSE/S I^ALID UNLESS SIGNED ^LOW Neither this license nor any right under this license shall be BY AUT^O^ED Nf^REPI^SENTATP^^

assigned or otherwise transferred in violation of the provisions of the Atomic Energy Act of 1954, as amended, and the Energy Reorganization Act of 1974. SIGNATURE:

This license is subject to the right of recapture or control by NAME AND TITLE: Peter J. t^ighorst,Wting Deputy Director Section 108 of the Atomic Energy Act of 1954, as amended, and Offi^ of International Programs to all of the other provisions of said Acts, now or hereafter in effect and to all valid rules and regulations of the NRC. nATF OF ISSUANCE: ^i ^

EXPORT LICENSE

XMAT433/01 Page 2 of 3 ULTIMATE CONSlGNEEfS)IN FOREIGN CUNTRYHES):

{For non-nuclear end use in the medical, pharmaceutical, chemical, and industrial markets)

{For non-nuclear end use in the medical, pharmaceutical, chemical, and industrial markets)

{For non-nuclear end use in the medical, pharmaceutical, chemical, and industrial markets)

INTERMEDIATE CONSIGNEEfS)IN FOREIGN COUNTRYflES):

{For distribution to ultimate consignees)

{For distribution to ultimate consignees)

XMAT433/01 Page 3 of 3 INTERMEDIATE CONSIGNEE(S)IN FOREIGN COUNTRYMES): (Cont'd)

(For distribution to ultimate consignees)

(For distribution to uitimate consignees)